The funds will help the company’s commercial expansion for the BEAR implant and clinical activities for it, according to a news release. The BEAR implant, which uses a patient’s blood to help treat ACL tears, has been used in nearly 3,000 patients.
The Major League Soccer Players Association, SV Health Investors and Aperture Venture Partners joined existing investors for the funding.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
